We can help you develop your product’s value story to reveal business insights for better decision-making.


Huanxue Zhou
Principal, HEOR / RWE
KMK has extensive experience in working with a variety of Real World Data (RWD), including administrative claims data, electronic health records, registries, and government databases.
Let's Talk

Want to learn more about our available candidates? Get in touch today.

Case Studies

Real World Evidence to Support Payer Negotiation

Leverage Anonymized Patient Level Data (APLD) to Identify Market Opportunities

Publication Area


Neurology: Clinical Practice

Unmet Need in the Market Economic Burden Increased with Number of Treatment Failures in Migraine Patients – A Retrospective Claims Database Analysis in the United States

KMK Participants : Lujia Zhou


The Journal of Headache and Pain

Real-world Product Value Demonstration Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

KMK Participants :Shen Y, Zhou L

Psoriatic arthritis

Springer-Drugs-Real World Outcomes

Association Between Treatment Patterns and Healthcare Utilization Healthcare Cost and Utilization Associated With Biologic Treatment Patterns Among Patients With Psoriatic Arthritis: Analyses From a Large US Claims Database

KMK Participants : Piao OW, Zheng JZ

Rheumatoid Arthritis

Rheumatology and Therapy

Understanding Real-world Patient Profiles & Identifying Primary Product Benefactor Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis

KMK Participant : Fahim M

Multiple Sclerosis

International Journal of MS Care

Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis

KMK Participants : Huanxue Zhou, Olivia Wenxian Piao 

Ankylosing spondylitis

Journal of Managed Care Specialty Pharmacy

Healthcare Utilization and Cost Associated With Switching Biologics Within the First Year of Biologic Treatment Initiation Among Patients With Ankylosing Spondylitis

KMK Participants : Piao OW, Zheng JZ

Multiple Sclerosis

Advances in Therapy

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

KMK Participants : Huanxue Zhou

Multiple Sclerosis

International Journal of MS Care

Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States

KMK Participants : Mengru Wang

Follicular Lymphoma


Treatment patterns and health care costs in commercially insured patients with follicular lymphoma

KMK Participants : Chen G

Related insights

Sorry, we couldn't find any posts. Please try a different search.